Surgical Versus Nonsurgical Treatment of Fibular Fractures: A Prospective Randomized Study
Launched by UNIVERSITY OF TENNESSEE · Jan 8, 2014
Trial Information
Current as of June 02, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Skeletally mature patients ≥ 18 years of age with acute, closed bimalleolar and/or trimalleolar ankle fractures
- • Operative fixation of the ankle fracture is within 3 weeks from date of injury
- • Bimalleolar and/or trimalleolar ankle fractures in which the medial malleolus fragment is greater than 1.7cm wide on lateral x-ray imaging
- • Bimalleolar and/or trimalleolar ankle fractures in which the posterior malleolus fragment is less than 20% of the depth of the tibial articular surface
- Exclusion Criteria:
- • Skeletally immature patients \< 18 years of age
- • Single malleolar ankle fractures
- • Open fractures
- • Operative fixation of the ankle fracture is more than 3 weeks from date of injury
- • Bimalleolar and/or trimalleolar fractures in which the medial malleolar fragment is less than or equal to 1.7cm wide on lateral x-ray imaging
- • Bimalleolar and/or trimalleolar ankle fractures in which the posterior malleolus fragment is greater than or equal to 20% of the depth of the tibial articular surface
- • Ankles with previous fractures of the medial and/or lateral malleolus requiring operative intervention
About University Of Tennessee
The University of Tennessee is a leading research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to improving patient outcomes and fostering scientific discovery, the university engages in a diverse range of studies that encompass various medical disciplines. Leveraging its extensive resources, expert faculty, and state-of-the-art facilities, the University of Tennessee collaborates with healthcare professionals and industry partners to translate research findings into practical applications. Through rigorous ethical standards and a patient-centered approach, the university aims to contribute significantly to the field of medicine and enhance the well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chattanooga, Tennessee, United States
Patients applied
Trial Officials
Dirk W Kiner, M.D.
Principal Investigator
UTCOM Chattanooga/Erlanger Health System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials